This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.

For healthcare professionals only

You are viewing the Novo Nordisk Virtual platform, provided to non-US health care professionals from around the world. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional.

 

This site is not country-specific and therefore may contain information which is not applicable to your country. Therefore, before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.

 

This site is not intended to provide medical advice and/or treatment guidance. Novo Nordisk accepts no liability for the accuracy, completeness or use of the information, and disclaims any liability to update the information contained on this site.

I hereby declare I am a non-US health care professional and that I have read and agreed to the terms mentioned above.

People living with diabetes can have different goals, expectations and social determinants for their care, emphasising the importance of personalised treatment goals and strategies to enhance diabetes management and quality of life.

 

Our goal is to inspire, educate, and empower all people affected by diabetes, and to promote an active and healthy lifestyle. Join us on our journey towards driving change in diabetes!

Team Novo Nordisk engages with patients, medical associations and policy makers to raise awareness about what is possible for people living with diabetes when we provide access to the best treatment. At the same time, we advocate for continued innovation to resolve unmet needs.

 

Get in touch with the team to learn more

Scientific innovation has unlocked significant improvements in the treatment and care of diabetes since the discovery of insulin. Thanks to continued innovation, new treatment options have reduced the risk of hypoglycaemia, improved convenience and simplified the burden of injections.

 

However, significant unmet needs remain, as 50% of those with diabetes don't meet treatment targets1, and 83% of people with type 1 diabetes experience at least one hypoglycemic event each month2. That’s why a continued effort and investment in research is needed to deliver solutions that can ensure optimal blood glucose control to reduce the risk of short- and long-term complications, reduce the daily burden of treatment and ultimately find a cure for diabetes.

Watch the inspiring story of Mandy Marquardt and let us shed light on the stigma around diabetes.

 

 

As a healthcare professional, you play a crucial role in empowering people with diabetes. Mandy’s experiences shed light on the impact of stigma and the challenges individuals with diabetes face, emphasizing the importance of support, especially during moments of vulnerability.

 

On average diabetes stigma affects four in five adults with diabetes and one in five experience discrimination3, impacting emotional well-being and treatment adherence for people living with diabetes. The stigma around diabetes also burdens health systems3, increasing both complications and costs. Ending diabetes stigma is necessary and urgent. International consensus has identified urgent action required to tackle stigma meaningfully.

 

 

 

Based on 10 years of learnings from the pro cyclists, a team of specialists have fine-tuned a holistic approach to ensure peak performance whilst maintaining good health. The guide is a tool for anyone who wants to pursue an endurance sport and use strategies and approaches to improve performance by committing to better understanding their own body’s response.

Download the guide

Delicious food for optimal performance

Discover tasty, diabetes-friendly recipes perfect for athletes and anyone looking for healthy meals. Share these recipes with your patients to help them maintain a healthy lifestyle.

1.

Avramidis I., Apsemidou A., Lalia A.Z. et al. Lessons From a Diabetes Clinic: Achieving Glycemic Goals and Clinical Use of Antidiabetic Agents in Patients With Type 2 Diabetes. Clinical Diabetes. 2020 Jul; 38(3): 248–255.

2.

Ratzki-Leewing A., Harris S.B., Meauanint S. et al. Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada. BMJ Open Diabetes Research & Care. 2018; 6(1): e000503.

3.

Speight J., Holmes-Truscott E., Garza M. et al. Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations. The Lancet Diabetes and Endocrinology. 2024 Jan; 12 (1): 61-82. https://doi.org/10.1016/S2213-8587(23)00347-9


The information contained in this site is intended for healthcare professionals only outside of the United States of America. This site is not intended to provide medical advice and/or treatment guidance. Only a physician can determine whether a specific product is correct for a particular patient. This site is not country-specific and therefore may contain information which is not applicable to your country. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional. Any images shown on the page are a mix of models and real patients.

 

HQ24NNG00054, May 2024